Certificate number:RU.77.99.11.003.Е.002233.05.17
Date of registration and renewal:17.05.2017
Dosage form: & nbspTablets weighing 1568 mg.
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes Supplements - macro and microelements
Classification "Clinical" & nbsp Supplements containing calcium and phosphorus Supplements containing selenium
Composition: & nbspVitamins (A, biotin, B1, B2, B6, B12, C, D, E, folic acid, K, nicotinamide, calcium pantothenate); Minerals and microelements: (calcium phosphate, magnesium oxide, chromium chloride, iron fumarate, potassium iodate, copper sulfate, manganese sulfate, sodium molybdate, calcium phosphate, sodium zinc selenate gluconate); auxiliary components: lactose monohydrate, E464, starch, Е551, Е471, Е332, Е464, Е470а, Е1201, Е904, Е171, Е553b, Е422, Е172, water, Е433.
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the sales network departments as a biologically active food additive - an additional source of vitamins and trace elements containing calcium, magnesium, phosphorus and selenium.
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:36 months.
Storage conditions:Keep in original packaging in a place inaccessible to children at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.003918.04.14 of 23.04.2014, the expert opinion of the FGBU Research Institute for Nutrition of RAMS №72 / Э-261 / б-14 of 06.03.2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp14.07.2017
Instructions
Up